New England Securities’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$65K Sell
631
-94
-13% -$9.02K 0.02% 529
2014
Q3
$63K Buy
725
+1
+0.1% +$89 0.02% 546
2014
Q2
$65K Buy
724
+32
+5% +$2.39K 0.02% 542
2014
Q1
$51K Buy
692
+3
+0.4% +$209 0.02% 561
2013
Q4
$47K Buy
689
+173
+34% +$11.3K 0.02% 556
2013
Q3
$31K Sell
516
-9
-2% -$549 0.02% 629
2013
Q2
$29K Buy
+525
New +$30.4K 0.02% 578

Other funds holding COV

New England Securities's COV Position: Q4 2014 in Review

New England Securities reduced its COVIDIEN PLC COM SHS NEW (IRELAND) (COV) stake by 13% in Q4 2014, selling an estimated $9.02K and leaving 631 shares worth $65K. The position accounts for 0.02% of the portfolio, ranked #529.

New England Securities first reported a position in COV in Q2 2013 and has held it in 7 quarters since. 758 funds tracked by Wall St. Rank hold COV as of Q4 2014.

  • New England Securities held 631 shares of COVIDIEN PLC COM SHS NEW (IRELAND) worth $65K as of Q4 2014.
  • New England Securities sold 94 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q4 2014, an estimated $9.02K.
  • COVIDIEN PLC COM SHS NEW (IRELAND) made up 0.02% of New England Securities's portfolio in Q4 2014, its #529 holding.
  • New England Securities first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and has held it in 7 quarters since.
  • 758 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.